The Securities Arbitration Law Firm of KlaymanToskes announced today that it is investigating the sale of BrioschiPharmaceuticals and private placements by FINRA brokerage firms Pinnacle Investments and Ridgeway & Conger. The investigation relates to whether the firms adequately disclosed material information concerning these investments and including the risks associated with these products were. A FINRA arbitration claim was recently filed relating to these investments. If you have information relating to this investigation, please contact KlaymanToskes, toll free, at 888-997-9956.
Founding Partner, KlaymanToskes
Lawrence L. Klayman
Managing and founding partner at KlaymanToskes. Former Wall Street securities broker with decades of experience representing high‑net‑worth and institutional investors nationwide. Has recovered over a quarter‑billion dollars for aggrieved investors and is frequently quoted in leading financial publications, including The Wall Street Journal, The New York Times, and Barron’s.
Covered on this page
